Urogen Pharma's total assets for Q2 2026 were $252.59M, a decrease of -0.43% from the previous quarter. DE:UR8 total liabilities were $384.99M for the fiscal quarter, a 1.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.